May 7th 2020
Michael Choi, MD, a medical staff physician and associate clinical professor of medicine at the University of California, San Diego (UCSD) Medical Center, discusses emerging treatments in chronic lymphocytic leukemia (CLL).
April 4th 2020
Michael Choi, MD, discusses the utility of duvelisib in chronic lymphocytic leukemia.
April 3rd 2020
Michael Choi, MD, discusses how up-front treatment decisions impact what options can be given in the relapsed/refractory setting for patients with chronic lymphocytic leukemia.